
Keywords: ARA; arachidonic acid (20:4n â 6); CVD; cardiovascular disease; DHA; docosahexaenoic acid (22:6n â 3); DPA; docosapentaenoic acid (22:5n â 3); EFA; essential fatty acid; Elovl; fatty acid elongase; EPA; eicosapentaenoic acid (20:5n â 3); F